Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T ... Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and CAR T Programs. Mehr anzeigen
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.68 | 6.25574977001 | 10.87 | 11.55 | 9.13 | 79218 | 10.13748439 | CS |
| 4 | 0.91 | 8.55263157895 | 10.64 | 13.64 | 9.13 | 72954 | 11.64007949 | CS |
| 12 | 3.83 | 49.6113989637 | 7.72 | 14.9299 | 7.2 | 101950 | 10.4389075 | CS |
| 26 | 1.96 | 20.4379562044 | 9.59 | 14.9299 | 6.5 | 112418 | 9.39960499 | CS |
| 52 | -2.45 | -17.5 | 14 | 39.5 | 6.5 | 1266041 | 18.24100958 | CS |
| 156 | -367.2 | -96.9504950495 | 378.75 | 443.75 | 4.965 | 1650091 | 70.22558623 | CS |
| 260 | -363.45 | -96.92 | 375 | 705 | 4.965 | 1345729 | 149.71767914 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
